State Street Corp Paratek Pharmaceuticals, Inc. Transaction History

State Street Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.52 - $2.8 $15,048 - $27,720	-9,900 Reduced 4.38%	216,110 $477,000
Q4 2022 Feb 14, 2023	BUY	$1.67 - $2.51 $29,893 - $44,928	17,900 Added 8.6%	226,010 $422,000
Q3 2022 Nov 15, 2022	SELL	$1.96 - $2.93 $14,504 - $21,682	-7,400 Reduced 3.43%	208,110 $535,000
Q2 2022 Aug 15, 2022	SELL	$1.73 - $3.09 $1.05 Million - $1.88 Million	-609,030 Reduced 73.86%	215,510 $416,000
Q1 2022 May 16, 2022	BUY	$2.94 - $4.77 $161,976 - $262,798	55,094 Added 7.16%	824,540 $2.45 Million
Q4 2021 Feb 14, 2022	BUY	$4.07 - $5.3 $44,814 - $58,358	11,011 Added 1.45%	769,446 $3.46 Million
Q3 2021 Nov 15, 2021	BUY	$4.7 - $7.24 $41,519 - $63,958	8,834 Added 1.18%	758,435 $3.69 Million
Q2 2021 Aug 16, 2021	BUY	$6.81 - $10.93 $406,693 - $652,739	59,720 Added 8.66%	749,601 $5.11 Million
Q1 2021 May 17, 2021	SELL	$6.14 - $8.31 $115,481 - $156,294	-18,808 Reduced 2.65%	689,881 $4.87 Million
Q4 2020 Feb 16, 2021	BUY	$4.58 - $7.14 $77,507 - $120,830	16,923 Added 2.45%	708,689 $4.44 Million
Q3 2020 Nov 10, 2020	BUY	$4.19 - $6.69 $189,107 - $301,939	45,133 Added 6.98%	691,766 $3.74 Million
Q2 2020 Aug 14, 2020	SELL	$2.97 - $5.22 $17,597 - $30,928	-5,925 Reduced 0.91%	646,633 $3.38 Million
Q1 2020 May 11, 2020	BUY	$2.67 - $4.97 $1.74 Million - $3.24 Million	652,558 New	652,558 $2.06 Million

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.